Patents by Inventor Ashfaq Parkar

Ashfaq Parkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9782411
    Abstract: {4-[5-(3-chloro-phenoxy)-oxazolo[5,4-d]pyrimidin-2-yl]-2,6-dimethyl-phenoxy}-acetic acid or a pharmaceutically acceptable salt thereof for use in the prevention or treatment of AKI (acute kidney injury). Medicament and pharmaceutical composition thereof.
    Type: Grant
    Filed: October 15, 2014
    Date of Patent: October 10, 2017
    Assignee: SANOFI
    Inventors: Véronique Briand, Sabine Gratzer, Thomas Huebschle, Philip Janiak, Dieter Kadereit, Ashfaq Parkar, Bruno Poirier, Matthias Schaefer, Paulus Wohlfart
  • Publication number: 20160235756
    Abstract: {4-[5-(3-chloro-phenoxy)-oxazolo[5,4-d]pyrimidin-2-yl]-2,6-dimethyl-phenoxy}-acetic acid or a pharmaceutically acceptable salt thereof for use in the prevention or treatment of AKI (acute kidney injury). Medicament and pharmaceutical composition thereof.
    Type: Application
    Filed: October 15, 2014
    Publication date: August 18, 2016
    Applicant: Sanofi
    Inventors: Véronique BRIAND, Sabine GRATZER, Thomas HUEBSCHLE, Philip JANIAK, Dieter KADEREIT, Ashfaq PARKAR, Bruno POIRIER, Matthias SCHAEFER, Paulus WOHLFART
  • Publication number: 20100152427
    Abstract: Described herein is a novel member of the prostanoid receptor family, a guinea pig prostaglandin D2 receptor. Described are the receptor, the nucleic acid that encodes it, and various uses for both.
    Type: Application
    Filed: February 23, 2010
    Publication date: June 17, 2010
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: Ashfaq PARKAR, Paul AUGUST, Theresa KUNTZWEILER, Mohamad Ali ARDATI, Namadev BASKARAN
  • Patent number: 7723074
    Abstract: Described herein is a novel member of the prostanoid receptor family, a guinea pig prostaglandin D2 receptor. Described are the receptor, the nucleic acid that encodes it, and various uses for both.
    Type: Grant
    Filed: January 6, 2009
    Date of Patent: May 25, 2010
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Ashfaq Parkar, Paul August, Theresa Kuntzweiler, Mohamad Ali Ardati, Namadev Baskaran
  • Publication number: 20090178151
    Abstract: Described herein is a novel member of the prostanoid receptor family, a guinea pig prostaglandin D2 receptor. Described are the receptor, the nucleic acid that encodes it, and various uses for both.
    Type: Application
    Filed: January 6, 2009
    Publication date: July 9, 2009
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: Ashfaq PARKAR, Paul AUGUST, Theresa KUNTZWEILER, Mohamad Ali ARDATI, Namadev BASKARAN
  • Patent number: 7488799
    Abstract: Described herein is a novel member of the prostanoid receptor family, a guinea pig prostaglandin D2 receptor. Described are the receptor, the nucleic acid that encodes it, and various uses for both.
    Type: Grant
    Filed: January 9, 2007
    Date of Patent: February 10, 2009
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Ashfaq Parkar, Paul August, Theresa Kuntzweiler, Mohamad Ali Ardati, Namadev Baskaran
  • Publication number: 20080020403
    Abstract: Described herein is a novel member of the prostanoid receptor family, a guinea pig prostaglandin D2 receptor. Described are the receptor, the nucleic acid that encodes it, and various uses for both.
    Type: Application
    Filed: January 9, 2007
    Publication date: January 24, 2008
    Applicant: Aventis Pharmaceuticals Inc.
    Inventors: Ashfaq Parkar, Paul August, Theresa Kuntzweiler, Mohamad Ardati, Namadev Baskaran
  • Publication number: 20070254937
    Abstract: Thienopyrazoles of formula I, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical uses in the treatment of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK).
    Type: Application
    Filed: March 6, 2006
    Publication date: November 1, 2007
    Applicant: Aventis Pharmaceuticals Inc.
    Inventors: John Jurcak, Matthieu Barrague, Timothy Gillespy, Michael Edwards, Kwon Musick, Philip Weintraub, Yan Du, Ramalinga Dharanipragada, Ashfaq Parkar
  • Patent number: 7183062
    Abstract: Described herein is a novel member of the prostanoid receptor family, a guinea pig prostaglandin D2 receptor. Described are the receptor, the nucleic acid that encodes it, and various uses for both.
    Type: Grant
    Filed: December 30, 2003
    Date of Patent: February 27, 2007
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Ashfaq Parkar, Paul August, Theresa Kuntzweiler, Mohamad Ali Ardati, Namadev Baskaran
  • Publication number: 20050142558
    Abstract: Described herein is a novel member of the prostanoid receptor family, a guinea pig prostaglandin D2 receptor. Described are the receptor, the nucleic acid that encodes it, and various uses for both.
    Type: Application
    Filed: December 30, 2003
    Publication date: June 30, 2005
    Applicant: Aventis Pharmaceuticals Inc.
    Inventors: Ashfaq Parkar, Paul August, Theresa Kuntzweiler, Mohamad Ardati, Namadev Baskaran